Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Myristoylated-peptidyl-recombinant SCR1-3 of human complement receptor type I

EU orphan designation number: EU/3/02/108
Active ingredient: Myristoylated-peptidyl-recombinant SCR1-3 of human complement receptor type I
Indication: Prevention of post transplantation graft dysfunction
Sponsor: Orexo AB
Virdings Allé 32 A, SE-754 50 Uppsala, Svërige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/08/2002 Orphan designation EMEA/OD/013/02 (2002)3015 of 30/07/2002
29/06/2007 Change of name and/or address of sponsor EMEA/OD/016/02
30/09/2008 Transfer of orphan designation EMEA/OD/013/02/T/01 (2008)5596 of 26/09/2008
03/03/2009 Removal of orphan designation from Community Register